Source:http://linkedlifedata.com/resource/pubmed/id/16298129
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2006-1-9
|
pubmed:abstractText |
The preparation and biological evaluation of 5-substituted-6-hydroxy-2-(anilino)pyrimidinones as a new class of DNA polymerase IIIC inhibitors, required for the replication of chromosomal DNA in Gram-positive bacteria, are described. These new dGTP competitive inhibitors displayed good levels of in vitro inhibition and antibacterial activity against Staphylococcus aureus. A new class of dATP competitive inhibitors, 6-substituted-2-amino-5-alkyl-pyrimidin-4-ones, whose antibacterial activity was unaffected by serum, were identified.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
891-6
|
pubmed:meshHeading |
pubmed-meshheading:16298129-DNA Polymerase III,
pubmed-meshheading:16298129-Dose-Response Relationship, Drug,
pubmed-meshheading:16298129-Enzyme Inhibitors,
pubmed-meshheading:16298129-Microbial Sensitivity Tests,
pubmed-meshheading:16298129-Molecular Structure,
pubmed-meshheading:16298129-Pyrimidinones,
pubmed-meshheading:16298129-Staphylococcus aureus,
pubmed-meshheading:16298129-Structure-Activity Relationship
|
pubmed:year |
2006
|
pubmed:articleTitle |
Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.
|
pubmed:affiliation |
Targanta Therapeutics Inc., 7170 Frederick-Banting, 2nd Floor, Montréal, Québec, Canada H4S 2A1. yrose@targanta.com
|
pubmed:publicationType |
Journal Article
|